Aplastic Anemia, Myelodysplasia, and Related Bone Marrow Failure Syndromes Flashcards
Course of aplastic anemia after immunosuppressive Rx
15% may develop MDS heralded by reappearance of pancytopenia
leukemia
hemolysis due to PNH
Phenotype of fanconi anemia patients
short stature
cafe au lait spots
thumb and radii abnormalities
genitourinary tract abnormalities
Time for granulocyte count improvement in aplastic anemia after immunosuppressive Rx
2 months
Anticonvulsants associated with aplastic anemia
hydantoins
carbamazepine
phenacemide
felbamate
In aplastic anemia evidence of replacement of marrow by fat is seen in
BMA
MRI spine
PS in aplastic anemia
large erythrocytes
paucity of platelets and granulocytes
Most common infectious cause of bone marrow failure
Hepatitis
Blood picture in myelofibrosis
anemia is dominant
normochromic,normocytic
Systemic diseases causing pancytopenia with cellular marrow
Systemic lupus erythematosus
Hypersplenism B12, folate deficiency Overwhelming infection Alcohol Brucellosis Sarcoidosis Tuberculosis Leishmaniasis
cytogenetics with good prognosis in MDS
del 5q
del 20q
Late effects of radiation
MDS
Leukemia
Not aplastic anemia
Presentation of eosinophilic fascitis
painful induration of subcutaneous tissue
Hematopoietic cells occupy less than _____ % of marrow space in aplastic anemia
25
severe cases fat is 100%
Mean age of onset of MDS
70 years
Infection as initial manifestation of aplastic anemia
Unusual
Cytogenetic abnormalities associated with MDS
del 5,7,20
trisomy 8(responds to immunosuppressive therapy)
11q23(topoisomerase inhibitors)
t(5;12)CMML
Infectious cause of marrow fibrosis
Mycobacteria
fungi
HIV
PS: Nucleated RBCs with pancytopenia
Marrow fibrosis
tumor invasion of marrow
Shwachman-Diamond syndrome
Marrow failure
pancreatic insufficiency leading to malabsorption
Bone marrow in MDS
hypercellular or normal
20%-hypocellular
ringed sideroblasts in erythroid lineage
megaloblastic nuclei with defective hemoglobinisation
increase in myeloblasts
granulocytic precursor and megakaryocyte abnormalities
Monoclonal antibody is useful in MDS pts with which characteristics
young(
favourable IPSS
HLA-DR15
MCV in aplastic anemia
Increased
Skin and joint symptoms of parvo virus infection are due to
immune complex deposition
Which is more common in MDS? aneuploidy or translocations
Aneuploidy
MDS blood studies
Anemia alone or as a part of bi/pancytopenia
isolated thrombocytopenia/granulocytopenia is rare
macrocytes
dimorphic anemia
Platelets are large and lack granules
Total WBC count is normal or low
Neutrophils are hypogranulated,ringed or hyposegmented nuclei
poor prognostic factors in MDS
Therapy related MDS
worsening of pancytopenia
acquisition of new chromosomal abnormalities (chromosome 7 abnormalities)
increase in the number of blasts
marrow fibrosis
peripheral smear in myelofibrosis
leukoerythroblastosis
nucleated RBC,tear drop
leukemoid reaction like picture
abundant,giant platelets
Phenotype of dyskeratosis congenita
mucous membrane leukoplakia
dystrophic nails
reticular hyperpigmentation
Family history suggestive of constitutive etiology of aplastic anemia
hematologic disorders
pulmonary or hepatic fibrosis
myelophthisis
secondary myelofibrosis
Immune diseases causing aplastic anemia
Eosinophilic fasciitis
Hyperimmunoglobulinemia
Thymoma/thymic carcinoma
Graft-versus-host disease in immunodeficiency
Mutation in PNH
PIG-A
Treatment of persistent B19 infection
Intravenous immunoglobulin therapy (e.g., 0.4 g/kg daily for 5 days)
Connective tissue disorders with PRCA
SLE
RA
JRA
Cytopathic sign of parvovirus B19 infection
Giant pronormoblast
Bone marrow failure states
aplastic anemia, myelodysplastic syndrome (MDS), pure red cell aplasia (PRCA), and myelophthisis
Etiology of most cases of aplastic anemia
idiopathic
congenital thrombocytopenia
Amegakaryocytic thrombocytopenia
Thrombocytopenia with absent radii
Presentation of hepatits induced pancytopenia
young men
hepatits due to non-A, non-B, non-C cause 1-2 months earlier
Dry tap with pancytopenia
Myelofibrosis
Myelophthisis
Drugs causing PRCA
phenytoin, azathioprine, chloramphenicol, procainamide, isoniazid,erythropoietin
Diagnosis of parvovirus infection
Detection of viral DNA sequences in the blood (IgG and IgM antibodies are commonly absent)
Management of anemia in aplastic anemia
2 units every 2 weeks
deferoxamine and deferasirox at fiftieth transfusion
Target Hb: 7 g/dl(9 g/dl if underlying cardiac or pulmonary disease is present)
MDS
cytopenia with dysmorphic and usually cellular marrow
Role of lenalidomide in MDS
Reverses anemia in MDS patients with 5q deletion
pathophysiologic features of myelophthisis
proliferation of fibroblasts in the marrow space
myeloid metaplasia(spleen,liver,nodes,long bones)
ineffective erythropoiesis
Cause of aplastic anemia in immunodeficient patients
Transfusion-associated graft-versus-host disease (GVHD)
Congenital agranulocytosis
Kostmann’s syndrome
Shwachman-Diamond syndrome
Most common isolated cytopenia
agranulocytosis
Characteristics of hypoproliferative anemias
normochromic, normocytic, or macrocytic and are characterized by a low reticulocyte count
PS: abnormal platelets with pancytopenia
MDS
peripheral destruction
Age distribution of acquired aplastic anemia
biphasic
Management of bleeding in aplastic anemia
Platelet transfusions to maintain count >10,000/µL(SDAP or HLA matched platelet transfusions)
Suppression of menstruation
avoid NSAID
Rx for aplastic anemia
HSCT
ATG+cyclosporine
high dose cyclophosphamide
? androgens(increase telomerse activity)
Hematologic syndromes that can cause myelofibrosis
CML
Hairy cell leukemia
MM
lymphoma
Viral causes of aplastic anemia
Epstein-Barr virus (infectious mononucleosis)
Hepatitis (non-A, non-B, non-C hepatitis)
Parvovirus B19 (transient aplastic crisis, PRCA)
HIV-1 (AIDS)
Empirical treatment of infections in aplastic anemia
broad spectrum antibiotics
ceftazidime or combination of aminoglycosides,cephalosporines,semisynthetic penicillin
Chemical causing aplastic anemia
Benzene
Inherited causes of aplastic anemia
Fanconi’s anemia
Dyskeratosis congenita
Shwachman-Diamond syndrome
Reticular dysgenesis
Amegakaryocytic thrombocytopenia
Familial aplastic anemias
Preleukemia (monosomy 7, etc.)
Nonhematologic syndrome (Down, Dubowitz, Seckel)
Dyskeratosis congenita
Drugs used in MDS
Azacitidine s.c
Decitabine i.v
pancytopenia with granulomas in bone marrow
Infectious etiology
Correlation between marrow cellularity and severity of aplastic anemia
imperfect
marrow cellularity decreases with aging
X linked dyskeratosis congenita is due to mutations in
DKC1(dyskerin)
Dyskeratosis is due to mutations in
telomere repair complex
Progression to pancytopenia or leukemia in single lineage failure syndromes
unusual
Treatment of aplastic anemia in older pts
Immunosuppresion is preferred
profound neutropenia: transplant
Viral causes of PRCA
Persistent B19 parvovirus, hepatitis, adult T cell leukemia virus, Epstein-Barr virus
Persistent or recrudescent fever in aplastic anemia
fungal infection
candida
aspergillus
clastogenic agents
Mitomycin C
diepoxybutane
Congenital PRCA
Diamond-Blackfan anemia
Parvovirus tropism for erythroid precursors is due to
Use of erythrocyte P antigen as cellular receptor for entry
DD for MDS
B12,folate,B6 deficiency
AML
Aplastic anemia
Antibiotics associated with aplastic anemia
chloramphenicol
quinacrine
chloroquine
sulfonamides
Demography of agranulocytosis
older adults and women
Pancytopenia with hypocellular marrow
Acquired aplastic anemia
Constitutional aplastic anemia (Fanconi’s anemia, dyskeratosis congenita)
Some myelodysplasia
Rare aleukemic leukemia
Some acute lymphoid leukemia
Some lymphomas of bone marrow
Tumors causing PRCA
Thymoma
Lymphoid malignancies
Paraneoplastic syndrome of solid tumors
Skin lesions in MDS
Sweet syndrome
Drugs associated with aplastic anemia
NSAID(esp phenylbutazone)
Heavy metals (gold, arsenic, bismuth, mercury)
antithyroid drugs (methimazole, methylthiouracil, propylthiouracil)
antidiabetes drugs (tolbutamide, chlorpropamide)
carbonic anhydrase inhibitors (acetazolamide and methazolamide)
Antihistamines (cimetidine, chlorpheniramine)
d-Penicillamine
Estrogens
Highly atypical physical examination features in aplastic anemia
lymphadenopathy
splenomegaly
Which diseases can evolve to MDS
acquired aplastic anemia following immunosuppressive treatment and Fanconi’s anemia
Poor prognostic factors in aplastic anemia
ANC
Platelet count
corrected reticulocyte count< 1% or absolute reticulocyte count
Daclizumab
antibody to the high affinity IL-2 receptor
In utero B19 parvovirus infection
Nonimmune hydrops fetalis
Rx of idiopathic PRCA
glucocorticoids,cyclosporine, ATG, azathioprine, cyclophosphamide, and daclizumab
Monoclonal ab used in MDS
Anti CD52
Alemtuzumab
Adverse effects of lenalidomide
thrombocytopenia
neutropenia
DVT/PE
Causes of hypocellular marrow with or without cytopenias
Q fever
Legionnaires’ disease
Anorexia nervosa, starvation
Mycobacterium
azacytidine
Pyramidine analogue
cytotoxic and demethylating agent
time required for correction of anemia with lenalidomide therapy in MDS
3 months
Systemic complaints and weight loss in aplastic anemia
Point to other etiologies
side effects of azacitidine and decitabine
Myelosuppression
Most common early symptom in aplastic anemia
bleeding
Role of vancomycin in aplastic anemia
contamination of indwelling plastic catheters
Difference between MDS and aplastic anemia
Morphologic abnormalities of megakaryocytes and myeloid precursor cells
typical cytogenetic abnormalities
Causes of secondary marrow fibrosis
Sarcoidosis
gaucher
osteopetrosis
radiation or radiomimetic alkylating agents
solid tumors causing marrow fibrosis
lung
breast
prostate
neuroblastoma
Presentation of acquired aplastic anemia
abrupt onset of low blood counts in a previously well young adult
PS: presence of immature myeloid forms with pancytopenia
Leukemia
MDS
Role of Hematopoietic growth factors in aplastic anemia
No role
Best Rx for young patient with aplastic anemia
fully histocompatible sibling donor HSCT
Physical signs in MDS
Pallor
Splenomegaly(20%)
Family h/o MDS
fanconi
sideroblastic anemia
Most common type of MDS
Refractory anemia with excess blasts
Immunosuppressive Rx in aplastic anemia
ATG and cyclosporine
Self limited causes of PRCA
Transient erythroblastopenia of childhood
Transient aplastic crisis of hemolysis (acute B19 parvovirus infection)
Side effect of ATG treatment
serum sickness
flu like illness
rash
arthralgia
occurs 10 days after initiating treatment
PRCA can be major manifestation of which lymphoid tumors
Large granular lymphocytosis
CLL
Side effects of cyclosporine
hypertension
nephrotoxicity
seizures
Pcp infection
BMA in aplastic anemia is _________ on smear
dilute
Secondary MDS
Radiation
Benzene
Radiomimetic alkylating agents( busulfan, nitrosourea, or procarbazine )
DNA topoisomerase inhibitors
Children with down syndrome are susceptible to
MDS
AML
Primary bone marrow diseases causing pancytopenia with cellular marrow
Myelodysplasia
Paroxysmal nocturnal hemoglobinuria Myelofibrosis Some aleukemic leukemia Myelophthisis Bone marrow lymphoma Hairy cell leukemia